Medical News

RSS

SARS-CoV-2 infection risk among dialysis patients during Omicron surge

A recent study posted to the medRxiv* preprint server evaluated the antibody responses against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) patients receiving hemodialysis.

22 Mar 2022

Association between seropositivity and comorbidities after COVID-19 vaccination

In a recent study posted to the medRxiv* preprint server, researchers demonstrated that comorbidities attenuated the chance of seropositivity following coronavirus disease 2019 (COVID-19) vaccination.

22 Mar 2022

Is COVID-19 on the verge of ending?

Researchers explore the changes arising in SARS-CoV-2 over time.

21 Mar 2022

Researchers receive a combined $1 million grant to study RET-positive lung cancer

University of Colorado Cancer Center member Tejas Patil, MD, is one of three researchers to receive a combined $1 million grant from the Hamoui Foundation and LUNGevity Foundation to study RET-positive lung cancer.

21 Mar 2022

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

Researchers demonstrate the broad neutralization potential of a strategically engineered circRNA using mice as a model system.

21 Mar 2022

Novel screening platform flags 95% of stage 1 cancers

A novel screening platform has flagged more than 95 percent of stage 1 cancers, according to a pilot study published in Nature Communications Medicine. If validated by future studies, the approach offers a new way to detect the third-leading cause of U.S. cancer deaths in 2020.

21 Mar 2022

Could COVID-19 spread through wastewater in the Thames?

Researchers investigate the presence of SARS-CoV-2 infectious particles and its RNA material in the Thames and other rivers.

21 Mar 2022

Factors influencing Australian mothers to vaccinate kids against COVID-19, get tested, and self-isolate

A new study investigates whether family demographic factors were associated with mothers’ willingness to vaccinate their four-year-old children.

21 Mar 2022

Researchers win NIH grant to treat human brain cancer with a drug previously used on canines

The National Institutes of Health is awarding a $3.8 million grant to John Rossmeisl, the Dr. and Mrs. Dorsey Taylor Mahin Professor of Neurology and Neurosurgery at the Virginia-Maryland College of Veterinary Medicine, and Waldemar Debinski, cancer biology professor at the Wake Forest School of Medicine.

21 Mar 2022

Using CRISPR/Cas to develop biosafety materials

Researchers discuss the use of the highly efficient CRISPR/Cas technologies to identify viral genome sequences for biosafety purposes.

21 Mar 2022

Most individuals treated in emergency departments for opioid use disorder do not sustain treatment

Most people who fill prescriptions from emergency physicians to treat their opioid use disorder do not continue to receive the medication, suggesting new approaches are needed to help people continue drug treatment begun on an emergency basis, according to a new RAND Corporation study.

21 Mar 2022

SARS-CoV-2 transmitters have 3 times higher viral loads than non-transmitters

Researchers discuss the difference between transmitters and non-transmitters of SARS-CoV-2 in terms of their mean viral load.

21 Mar 2022

Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

A team of clinical investigators at the Icahn School of Medicine at Mount Sinai has announced the launch of a Phase 1, open-label, placebo-controlled study to evaluate the safety and immunogenicity of an egg-based COVID-19 vaccine in healthy, vaccinated adults who have never been infected with COVID-19.

21 Mar 2022

Using a new data-driven approach to understand more about people with Type 1 diabetes

An interdisciplinary team of researchers from the University of Missouri, Children's Mercy Kansas City and Texas Children's Hospital has used a new data-driven approach to learn more about persons with Type 1 diabetes, who account for about 5-10% of all diabetes diagnoses.

21 Mar 2022

Trial reveals effectiveness of axi-cel as first-line treatment for high-risk lymphoma

Results from the ZUMA-12 trial led by researchers at The University of Texas MD Anderson Cancer Center showed that first-line treatment with axicabtagene ciloleucel (axi-cel), a chimeric antigen receptor (CAR) T cell therapy, achieved a high rate of complete response in patients with high-risk large B-cell lymphoma (LBCL).

21 Mar 2022

Covid-19 patients are at increased risk of developing type 2 diabetes, study shows

People who have had Covid-19 are at increased risk of developing type 2 diabetes. This is the result of a study by DDZ, DZD and IQVIA, which has now been published in Diabetologia.

21 Mar 2022

Intranasal delivery of pro-resolving lipid mediators arrests memory loss in experimental Alzheimer’s model

A research collaboration between scientists at LSU Health New Orleans and the Karolinska Institutet in Sweden has found that applying specialized pro-resolving lipid mediators intranasally arrested memory loss and brain degeneration in an experimental model of Alzheimer's Disease (AD).

21 Mar 2022

Medical News

SARS-CoV-2 infection risk among dialysis patients during Omicron surge

Association between seropositivity and comorbidities after COVID-19 vaccination

Is COVID-19 on the verge of ending?

Researchers receive a combined $1 million grant to study RET-positive lung cancer

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

Novel screening platform flags 95% of stage 1 cancers

Could COVID-19 spread through wastewater in the Thames?

Factors influencing Australian mothers to vaccinate kids against COVID-19, get tested, and self-isolate

Researchers win NIH grant to treat human brain cancer with a drug previously used on canines

Using CRISPR/Cas to develop biosafety materials

Most individuals treated in emergency departments for opioid use disorder do not sustain treatment

SARS-CoV-2 transmitters have 3 times higher viral loads than non-transmitters

Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

Using a new data-driven approach to understand more about people with Type 1 diabetes

Trial reveals effectiveness of axi-cel as first-line treatment for high-risk lymphoma

Covid-19 patients are at increased risk of developing type 2 diabetes, study shows

Intranasal delivery of pro-resolving lipid mediators arrests memory loss in experimental Alzheimer’s model

Researchers find effective nutritional strategies to prevent acute kidney injury

IU researchers exploring new ways to treat seasonal or intermittent asthma

AI system can help detect the degree and severity of heart transplant rejection

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News